Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.2920
-0.0060 (-2.01%)
At close: Apr 9, 2026
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 20.38 million as of April 9, 2026. Its market cap has increased by 9.96% in one year.
Market Cap
20.38M
Enterprise Value
17.90M
Revenue
32.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 20.38M, a decrease of -42.00%. That is a compound annual growth rate of -2.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 20.38M | -0.67% |
| Dec 30, 2025 | 20.52M | 8.70% |
| Dec 30, 2024 | 18.88M | -27.02% |
| Dec 29, 2023 | 25.87M | -45.31% |
| Dec 30, 2022 | 47.30M | -70.97% |
| Dec 30, 2021 | 162.94M | 142.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JonDeTech Sensors AB | 27.35M |
| Spermosens AB | 26.65M |
| Relevance Communication Nordic AB | 26.57M |
| Nattaro Labs AB | 25.93M |
| Vaxxa AB | 25.33M |
| Goobit Group AB | 24.40M |
| Cardeon AB | 24.37M |
| Transiro Holding AB | 24.36M |